Trust the source, not just the story
Nikkei Asia
Nikkei Asia
AsiaPac · 1 hrs ago
Taiwan's biopharma sector steps into spotlight with rush of IPOs
BiotechnologyTaipei fosters growth to support economy, security alongside semiconductorsA lab where Taiwan Bio-Manufacturing Corp. conducts process analysis and development for biopharmaceutical products. (TBMC)RYOSUKE EGUCHIJuly 7, 2026 05:54 JSTTAIPEI -- Taiwan's biopharmaceutical sector is growing, with seven companies going public in the first half of 2026, helped by the government's push to nurture the next strategic industries after semiconductors.
Nikkei Asia
Do you trust Nikkei Asia?
Sign in to rate
Discussion 0 comments
Sort:
?

No comments yet — be the first to start the discussion!